4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-26-032559
CEO, CFO sold 146,798 shares at $2.07 ($303,343)
- CEO, CFO acquired 335,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Finley John David · CEO, CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-06 | Exercise or conversion : show line 1 in the form | +335,167 | 364,353 | D | ||
| 2026-07-07 | Sale : show line 2 in the form | −146,798 | $2.07 | $303,343 | 217,555 | D |
| 2026-07-07 | Exercise or conversion : show line 3 in the form | +133 | $0.70 | $93 | 217,688 | D |
| Open-market sales · 146,798 sh · avg $2.07 · $303,343 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-06 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −335,167 | 1,675,833 | D |
| 2026-07-07 | Exercise or conversion : show line 5 in the form Series 2 Common Stock Purchase Warrant | −133 | 0 | D |
Loading xslF345X06/ownership.xml…